Dr. Kevin P. Redmond, MD

Dr. Redmond practices at UC Medical Center in Cincinnati, Ohio.

Dr. Redmond's NPI, 1528050481, was assigned on August 17, 2005. Dr. Redmond graduated from University of Cincinnati College of Medicine in 1982. Dr. Redmond holds Ohio license 35-04-9201.

Dr. Redmond's primary practice is UC Medical Center, at 3188 Bellevue Ave, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 584-1000.

Dr. Redmond's primary practice is UC Medical Center in Cincinnati, Ohio. Dr. Redmond is also affiliated with University of Cincinnati Medical Center. The medical group on file is Cincinnati Children's. Dmand AI also links Dr. Redmond to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Redmond practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Redmond's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Redmond is licensed in Ohio.

CMS data shows 460 Medicare services from Dr. Redmond across 11 procedure codes in 2024, for 148 Medicare patients. Medicare paid $31,640 for them. Every service was in an office.

CMS counts 148 Medicare patients who saw Dr. Redmond in 2024. The largest group is 65 to 74, with 75 patients. 74% of them have high blood pressure, and 71% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Redmond's median patient age at 66, with 27% women.

In 2024, Dr. Redmond wrote 127 Medicare Part D claims for 44 patients. 95% of them were for generic drugs. CMS names the drug for 51 of them, across 2 drugs with 11 or more claims each, at $803 in total drug cost. In 2023, CMS named 43 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Redmond for performance year 2024, reported as part of a group. Dr. Redmond accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Redmond, published from 2013 to 2023. 2021 was the busiest year, with 2. The most frequent topics are Radiotherapy Dosage. Dr. Redmond's most frequent co-authors are Vinita Takiar, MD, Paul J. Kreinbrink, MD and Christine H. Chung, MD.

Dmand AI links Dr. Redmond to 10 clinical trials, 4 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Tongue Neoplasms, Tongue Diseases and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 16 general payments to Dr. Redmond from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $77.

Dr. Redmond graduated from University of Cincinnati College of Medicine in 1982.